KATHLEEN MILAM: Open Payments
NPI 1346480449 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,795 in 144 payments from 31 companies in 2025. Trend: 2023 $1,773 · 2024 $2,227 · 2025 $2,795
Food & beverage: $2,596Education: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $478 |
| Daiichi Sankyo Inc. | 12 | $374 |
| AstraZeneca Pharmaceuticals LP | 17 | $321 |
| Janssen Biotech, Inc. | 10 | $312 |
| Merck Sharp & Dohme LLC | 12 | $168 |
| PFIZER INC. | 12 | $151 |
| Novartis Pharmaceuticals Corporation | 7 | $135 |
| Eisai Inc. | 6 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| Exelixis Inc. | 5 | $83 |
Products named: Enhertu, EPKINLY, RYBREVANT, KEYTRUDA, IMFINZI, Lenvima, IBRANCE, KISQALI.
Industry payments across AR — which companies pay providers there.
